Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independ...
February 09 2021 - 8:30AM
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer
of computerized drug delivery instruments that provides virtually
painless and precise injections, today announced that it has signed
two additional distribution agreements with Atlanta Dental and
Nashville Dental for its Wand® Single Tooth Anesthesia (STA)
System. Atlanta Dental and Nashville Dental are leading
distributors of dental products in the U.S., headquartered in
Atlanta and Tennessee, respectively.
Arjan Haverhals, CEO of Wand Dental Inc.
commented, “In less than a month, we have expanded our network to
include four new independent distributors covering key markets
across the U.S. with extensive expertise and proven track records
in launching new dental products. We believe our rapid progress
illustrates the positive response and growing market demand for our
dental instrument. Atlanta Dental and Nashville Dental will be
important additions to our distribution network as we educate
dental professionals on the significant benefits of our dental
instrument, including safety, efficiency, and, importantly,
supporting the growth of dental practices. We believe these
relationships will help boost sales of our dental instruments and
drive incremental high margin, recurring handpiece sales in the
coming years. We look forward to further expanding our coverage and
working closely with our new distributors.”
“We have begun implementing our three-year
strategy to expand the world-wide global dental market and are
successfully adding domestic and global distribution partners. We
believe that with this decentralized sales strategy in combination
with our increased marketing efforts, we can further grow the
dental business in the future.”
About Atlanta Dental
Since 1868 Atlanta Dental has focused
exclusively on serving the customers with quality dental Products,
Services, and Technology. The mission of Atlanta Dental is to build
relationships that are both lasting and rewarding through the
precise delivery of product, service & technology solutions to
the dental profession and to be the industry leader in the
Southeast that cultivates customer, employee and vendor
satisfaction while meeting the growth and profit objectives. For
more information, please visit: https://atlantadental.com/.
About Nashville Dental
Founded in 1897 in Nashville, Tennessee,
Morrison Brothers Dental Supply Company incorporated in 1905 and
changed its name to Nashville Dental, Inc (NDI). NDl offers
numerous products, services and solutions to support the local
dental profession. NDI is passionate about the value the
independent dental practices and groups bring our local
communities. The only locally owned supplier in the region, NDI now
brings comprehensive product choice to Tennessee, Kentucky,
Alabama, north Georgia, north Mississippi, West Virginia, southwest
Virginia and southern Indiana. For more information, please visit:
https://nashvilledental.com/.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical
technology research and development company that patents, designs
and develops innovative diagnostic and therapeutic injection
technologies and instruments for medical, dental, cosmetic and
veterinary applications. Milestone's computer-controlled systems
are designed to make injections precise, efficient, and virtually
painless. Milestone’s proprietary DPS Dynamic Pressure Sensing
technology® is our technology platform that advances the
development of next-generation devices, regulating flow rate and
monitoring pressure from the tip of the needle, through platform
extensions for local anesthesia for subcutaneous drug delivery,
with specific applications for cosmetic botulinum toxin injections,
epidural space identification in regional anesthesia procedures and
intra-articular joint injections. For more information please visit
our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2019. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact:David Waldman or
Natalya RudmanCrescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024